Dr. Amy Lucas Nance, MD

Dr. Nance practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Gainesville, Florida.

Dr. Nance's NPI, 1407032097, was assigned on January 14, 2008. Dr. Nance graduated from Mercer University School of Medicine in 2005. Dr. Nance holds Florida license ME131863.

Dr. Nance's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 6440 W Newberry Rd, Gainesville, FL 32605 in Alachua County. The practice phone is (239) 541-4633.

Dr. Nance's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Gainesville, Florida. Dr. Nance is also affiliated with HCA Florida North Florida Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Nance to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nance practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Nance's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Nance is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Nance's licenses on file in 3 states: Florida, Georgia and Tennessee.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Nance treats.

CMS data shows 191,231 Medicare services from Dr. Nance across 45 procedure codes in 2024, for 1,000 Medicare patients. Medicare paid $1,164,173 for them.

CMS counts 1,000 Medicare patients who saw Dr. Nance in 2024. The largest group is 75 to 84, with 422 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nance's median patient age at 69, with 69% women.

In 2024, Dr. Nance wrote 1,164 Medicare Part D claims for 248 patients. 79% of them were for generic drugs. CMS names the drug for 984 of them, across 36 drugs with 11 or more claims each, at $1,758,660 in total drug cost. In 2023, CMS named 744 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nance for performance year 2024, reported as part of a group.

CMS Open Payments shows 331 general payments to Dr. Nance from 64 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $765.

Dr. Nance graduated from Mercer University School of Medicine in 2005.

Dr. Nance is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.